Converting Oral Hydromorphone to Transdermal Fentanyl Patch
Calculate the total daily oral hydromorphone dose, use established conversion tables to determine the appropriate fentanyl patch strength, prescribe short-acting opioid breakthrough medication for the first 8-24 hours, and monitor closely for the first 2-3 days before making any dose adjustments. 1
Step-by-Step Conversion Algorithm
Step 1: Calculate Total Daily Hydromorphone Dose
- Sum all hydromorphone doses taken in a 24-hour period 1
- Include both scheduled and as-needed doses that were actually taken
Step 2: Determine Fentanyl Patch Dose Using Conversion Table
Use the NCCN conversion table directly since hydromorphone is listed 1:
- 7.5 mg/day oral hydromorphone = 25 mcg/h fentanyl patch
- 15 mg/day oral hydromorphone = 50 mcg/h fentanyl patch
- 22.5 mg/day oral hydromorphone = 75 mcg/h fentanyl patch
- 30 mg/day oral hydromorphone = 100 mcg/h fentanyl patch 1
For doses between these values, round down to the lower patch strength for safety 2.
Step 3: Apply the Patch and Discontinue Hydromorphone
- Apply the fentanyl patch to intact, non-irritated skin 2
- Discontinue all scheduled hydromorphone at the time of patch application 1, 2
- The patch takes 12-24 hours to reach therapeutic levels, so pain control may be suboptimal initially 1
Step 4: Prescribe Breakthrough Medication (Critical)
Prescribe immediate-release oral hydromorphone or morphine for breakthrough pain during the first 8-24 hours 1:
- Calculate breakthrough dose as 10-15% of the previous total daily hydromorphone dose 1
- Allow dosing every 1-2 hours as needed 1
- This is essential because fentanyl levels are still rising during this period 1
Step 5: Monitor and Titrate After Stabilization
Wait at least 2-3 days (one full patch cycle) before making dose adjustments 1:
- Fentanyl reaches steady-state after 2-3 days 1
- Track the total amount of breakthrough medication used over 24 hours 1
- If significant breakthrough medication is needed, increase the patch dose based on the average daily breakthrough requirement 1
Continue breakthrough medication indefinitely even after the patch dose is stabilized 1.
Critical Safety Considerations
Patient Selection Criteria
Only use fentanyl patches in opioid-tolerant patients 1, 2:
- The FDA defines opioid tolerance as taking at least 60 mg/day oral morphine equivalents for ≥1 week 2
- Pain must be relatively stable before initiating the patch 1
- Do NOT use patches for unstable pain requiring frequent dose changes 1
Contraindications and Warnings
Avoid heat exposure (fever, heating pads, electric blankets, heat lamps) as this accelerates fentanyl absorption and can cause overdose 1:
- Fever is a contraindication to transdermal fentanyl 1
Exercise extreme caution in cachectic patients 3:
- A case report demonstrated that a patient with cachexia developed opioid toxicity when rotating FROM fentanyl patch, requiring only 30% of the calculated equianalgesic dose 3
- Cachexia, weight loss, and advanced age can impair patch absorption unpredictably 3
Monitoring Parameters
During the first 72 hours, monitor for:
- Respiratory depression (respiratory rate, oxygen saturation) 2
- Sedation level using standardized scales 1
- Pain control using numeric rating scales 1
- Opioid withdrawal symptoms if converting from high-dose hydromorphone 1
Common Pitfalls to Avoid
- Starting the patch in opioid-naive patients - this can be fatal 2
- Failing to provide breakthrough medication during the first 24 hours when fentanyl levels are subtherapeutic 1
- Adjusting the patch dose too quickly before steady-state is reached (before 2-3 days) 1
- Using patches for unstable or rapidly escalating pain - oral or parenteral opioids are more appropriate 1
- Not accounting for heat exposure which can cause rapid, dangerous increases in fentanyl absorption 1